Silverarc Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$20.5M	Buy	162,969 +90,386	+125%	+$11.4M	3.78%	8
2025 Q1	$8.03M	Buy	+72,583	New	+$8.03M	1.64%	19
2022 Q2	–	Sell	-20,482	Closed	-$1.92K	–	71
2022 Q1	$1.92K	Buy	+20,482	New	+$1.92K	0.79%	30